Abstract:ObjectivesUsing quantitative coronary angiography (QCA), optical coherence tomography (OCT), histomorphometry, and pharmacokinetics, this study tried to evaluate the safety and efficacy of Biomagic rapamycin-eluting bioabsorbable scaffold (BVS) in non-atherosclerotic porcine coronary arteries.BackgroundBiomagic BVS is a new generation of thin-strut bioabsorbable scaffold. We conducted comparative study detailing pathological response, safety and efficacy of Biomagic BVS and the Firebird2 rapamycin-eluting cobalt-based alloy stent (DES) in a porcine coronary artery model. The animals were followed up at 14 days, 1, 3, 6, 12, 18, 24, 30, 36, 42, 48, 54, and 60 months after stent implantation.MethodsA total of 143 devices (95 Biomagic and 48 Firebird2) were implanted in 2 or 3 main coronary arteries of 76 nonatherosclerotic swine and examined by QCA, OCT, light microscopy, and pharmacokinetics analyses at various time points.ResultsVascular responses to Biomagic and Firebird2 were largely comparable at all time points, with struts being sequestered within the neointima. The degree of inflammation of both devices was mild to moderate, although the Biomagic score was higher at 14 days to 24 months. However, there was no statistical difference between the two groups except 14 days. At each follow-up time point, the percentage of area stenosis in the Biomagic group was greater than that in the Firebird 2 group, but there was no statistical difference between the two groups at 3 and 12 months. The extent of fibrin deposition was similar between Biomagic and Firebird2, which peaked at 1 month and decreased rapidly thereafter. Pharmacokinetic study showed that coronary tissue sirolimus concentration remained above 2 ng/mg of tissue at 28 day. Histomorphometry showed expansile remodeling of Biomagic-implanted arteries starting after 12 months, and lumen area was significantly greater in Biomagic than Firebird2 at 36 and 42 months. These changes correlated with dismantling of Biomagic seen after 12 months. OCT images confirmed that degradation of Biomagic was complete by 36 months.ConclusionsBiomagic demonstrates comparable long-term safety to Firebird2 in porcine coronary arteries with mild to moderate inflammation. Although Biomagic was associated with greater percent stenosis relative to Firebird2 within 36 months, expansile remodeling was observed after 12 months in Biomagic with significantly greater lumen area at ≥36 months. Scaffold resorption is considered complete at 36 months.

Degradation of a novel magnesium alloy-based bioresorbable coronary scaffold in a swine coronary artery model

Synchrotron microtomography reveals insights into the degradation kinetics of bio-degradable coronary magnesium scaffolds

In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications

Biosafety and Efficacy Evaluation of a Biodegradable Magnesium Based Drug-eluting Stent in Porcine Coronary Artery

Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery

In vivo degradation and endothelialization of an iron bioresorbable scaffold

Six-month Evaluation of Novel Bioabsorbable Scaffolds Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Arteries

Degradation behaviors and in-vivo biocompatibility of a rare earth- and aluminum-free magnesium-based stent

Evaluation of Long-Term Inflammatory Responses after Implantation of a Novel Fully Bioabsorbable Scaffold Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles

Very late Magmaris scaffold restenosis: a 6-year serial optical coherence tomography case report

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease

Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds.

Long-term outcomes following bioresorbable vascular scaffolds

Evaluation of Inflammatory and Calcification after Implantation of Bioabsorbable Poly-L-Lactic Acid/Amorphous Calcium Phosphate Scaffolds in Porcine Coronary Arteries

Five-year Comparative Study of Thin-Strut Rapamycin-Eluting Bioabsorbable Scaffold with Metallic Drug-Eluting Stent in Porcine Coronary Artery

PDLLA-Zn-nitrided Fe Bioresorbable Scaffold with 53-Μm-thick Metallic Struts and Tunable Multistage Biodegradation Function

Long-Term Efficacy, Safety and Biocompatibility of a Novel Sirolimus Eluting Iron Bioresorbable Scaffold in a Porcine Model

Coronary Artery Bypass at a Drug-Eluting Resorbable Magnesium Scaffold Site in a Porcine Model

In vivo comparison of the degradation and osteointegration properties of micro-arc oxidation-coated Mg-Sr and Mg-Ca alloy scaffolds

Optical coherence tomography characterization of degradation kinetics between second‐ and third‐generation resorbable magnesium scaffold

In vivo chronic scaffolding force of a resorbable magnesium scaffold